4.6 Article

p38 MAPK Down-regulates Fibulin 3 Expression through Methylation of Gene Regulatory Sequences ROLE IN MIGRATION AND INVASION

Journal

JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 290, Issue 7, Pages 4383-4397

Publisher

AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.M114.582239

Keywords

-

Funding

  1. Spanish Ministry of Economy and Competitiveness [SAF2010-20918-C02-01, SAF2103-48210-C2-02, SAF2010-20918-C02-02, SAF2103-48210-C2-01]
  2. Council of Health and Social Welfare
  3. Council of Education from Junta de Castilla y Leon, Spain [SA157A12-1]
  4. European FEDER Program
  5. Spanish Ministry of Education
  6. Spanish Ministry of Economy and Competitiveness

Ask authors/readers for more resources

p38 MAPKs regulate migration and invasion. However, the mechanisms involved are only partially known. We had previously identified fibulin 3, which plays a role in migration, invasion, and tumorigenesis, as a gene regulated by p38 alpha. We have characterized in detail how p38 MAPK regulates fibulin 3 expression and its role. We describe here for the first time that p38 alpha, p38 gamma, and p38 delta down-regulate fibulin 3 expression. p38 alpha has a stronger effect, and it does so through hypermethylation of CpG sites in the regulatory sequences of the gene. This would be mediated by the DNA methylase, DNMT3A, which is down-regulated in cells lacking p38 alpha, but once re-introduced represses Fibulin 3 expression. p38 alpha through HuR stabilizes dnmt3a mRNA leading to an increase in DNMT3A protein levels. Moreover, by knocking-down fibulin 3, we have found that Fibulin 3 inhibits migration and invasion in MEFs by mechanisms involving p38 alpha/beta inhibition. Hence, p38 alpha pro-migratory/invasive effect might be, at least in part, mediated by fibulin 3 down-regulation in MEFs. In contrast, in HCT116 cells, Fibulin 3 promotes migration and invasion through a mechanism dependent on p38 alpha and/or p38 beta activation. Furthermore, Fibulin 3 promotes in vitro and in vivo tumor growth of HCT116 cells through a mechanism dependent on p38 alpha, which surprisingly acts as a potent inducer of tumor growth. At the same time, p38 alpha limits fibulin 3 expression, which might represent a negative feed-back loop.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Hematology

Characterization of the Platelet Phenotype Caused by a Germline RUNX1 Variant in a CRISPR/Cas9-Generated Murine Model

Ana Marin-Quilez, Ignacio Garcia-Tunon, Cristina Fernandez-Infante, Luis Hernandez-Cano, Veronica Palma-Barqueros, Elena Vuelta, Manuel Sanchez-Martin, Jose Ramon Gonzalez-Porras, Carmen Guerrero, Rocio Benito, Jose Rivera, Jesus Maria Hernandez-Rivas, Jose Maria Bastida

Summary: RUNX1-related disorder is a rare and heterogeneous disease caused by germline variants affecting the RUNX1 gene, and using murine models can help elucidate its pathogenic mechanisms.

THROMBOSIS AND HAEMOSTASIS (2021)

Article Gastroenterology & Hepatology

Next-generation sequencing of bile cell-free DNA for the early detection of patients with malignant biliary strictures

Maria Arechederra, Maria Rullan, Irene Amat, Daniel Oyon, Lucia Zabalza, Maria Elizalde, M. Ujue Latasa, Maria R. Mercado, David Ruiz-Clavijo, Cristina Saldana, Ignacio Fernandez-Urien, Juan Carrascosa, Vanesa Jusue, David Guerrero-Setas, Cruz Zazpe, Iranzu Gonzalez-Borja, Bruno Sangro, Jose M. Herranz, Ana Purroy, Isabel Gil, Leonard J. Nelson, Juan J. Vila, Marcin Krawczyk, Krzysztof Zieniewicz, Waldemar Patkowski, Piotr Milkiewicz, Francisco Javier Cubero, Gorka Alkorta-Aranburu, Maite G. Fernandez-Barrena, Jesus M. Urman, Carmen Berasain, Matias A. Avila

Summary: The NGS mutational analysis of bile cfDNA, named Bilemut, showed a sensitivity of 96.4% and specificity of 69.2% for detecting malignancy in patients with suspicious biliary strictures. Implementation of Bilemut at the initial diagnostic stage can significantly improve detection of malignancy, reduce delays in clinical management, and assist in selecting patients for targeted therapies.
Review Biochemistry & Molecular Biology

C3G Protein, a New Player in Glioblastoma

Sara Manzano, Alvaro Gutierrez-Uzquiza, Paloma Bragado, Angel M. Cuesta, Carmen Guerrero, Almudena Porras

Summary: C3G, a guanine nucleotide exchange factor for GTPases from the Ras superfamily, has been found to be downregulated in GBM, promoting a mesenchymal phenotype and enhancing migration and invasion. It may serve as a potential biomarker for GBM diagnosis, prognosis, and personalized treatment, with the quantification of C3G levels in circulating tumor cells as a useful tool to improve patient outcomes.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Oncology

HOXD8 hypermethylation as a fully sensitive and specific biomarker for biliary tract cancer detectable in tissue and bile samples

Eleonora Loi, Cesare Zavattari, Alessandro Tommasi, Loredana Moi, Matteo Canale, Agnese Po, Claudia Sabato, Ana Florencia Vega-Benedetti, Pina Ziranu, Marco Puzzoni, Eleonora Lai, Luca Faloppi, Maria Rullan, Juan Carrascosa, Irene Amat, Jesus M. Urman, Maria Arechederra, Carmen Berasain, Elisabetta Ferretti, Andrea Casadei-Gardini, Matias A. Avila, Sergio Alonso, Mario Scartozzi, Patrizia Zavattari

Summary: In this study, we aimed to identify BTC-specific DNA methylation alterations. By performing a genome-wide methylation study and validating the findings in multiple samples, we successfully identified and validated BTC-specific DNA methylation alterations in over 200 BTC samples. Additionally, we discovered a biomarker associated with the HOXD8 gene that showed high sensitivity and specificity in detecting BTC in tissue and bile samples.

BRITISH JOURNAL OF CANCER (2022)

Article Oncology

Activation of the Unfolded Protein Response (UPR) Is Associated with Cholangiocellular Injury, Fibrosis and Carcinogenesis in an Experimental Model of Fibropolycystic Liver Disease

Chaobo Chen, Hanghang Wu, Hui Ye, Agustin Tortajada, Sandra Rodriguez-Perales, Raul Torres-Ruiz, August Vidal, Maria Isabel Peligros, Johanna Reissing, Tony Bruns, Mohamed Ramadan Mohamed, Kang Zheng, Amaia Lujambio, Maria J. Iraburu, Leticia Colyn, Maria Ujue Latasa, Maria Arechederra, Maite G. Fernandez-Barrena, Carmen Berasain, Javier Vaquero, Rafael Banares, Leonard J. Nelson, Christian Trautwein, Roger J. Davis, Eduardo Martinez-Naves, Yulia A. Nevzorova, Alberto Villanueva, Matias A. Avila, Francisco Javier Cubero

Summary: This study reveals the contribution of unfolded protein response activation and liver tissue scarring to the development of polycystic liver disease (PLD) and early cancer. The mutant mice used in this study serve as an ideal tool for investigating PLD and early cancer development. The findings suggest that activation of unfolded protein response and fibrosis may trigger the formation of hepatic cysts and early stages of cholangiocarcinoma (CCA).

CANCERS (2022)

Editorial Material Gastroenterology & Hepatology

Two is better than one: combinatorial receptor targeting enhances hepatocellular carcinoma (HCC) therapeutic response

Celia Sequera, Flavio Maina

HEPATOBILIARY SURGERY AND NUTRITION (2022)

Article Oncology

DNA Methylation Regulates a Set of Long Non-Coding RNAs Compromising Hepatic Identity during Hepatocarcinogenesis

Miriam Recalde, Maria Garate-Rascon, Jose Maria Herranz, Maria Elizalde, Maria Azkona, Juan P. Unfried, Loreto Boix, Maria Reig, Bruno Sangro, Maite G. Fernandez-Barrena, Puri Fortes, Matias A. Avila, Carmen Berasain, Maria Arechederra

Summary: This study identifies a set of lncRNAs that are significantly downregulated in hepatocellular carcinoma (HCC) and are related to tumor dedifferentiation and patients' prognosis. Mechanistically, these lncRNAs are involved in hepatic differentiation and their expression is silenced by DNA methylation in HCC. These findings provide insights into the progression of liver cancer and potential new biomarkers.

CANCERS (2022)

Article Cell Biology

Enhanced Wild-Type MET Receptor Levels in Mouse Hepatocytes Attenuates Insulin-Mediated Signaling

Patricia Rada, Fabienne Lamballe, Elena Carceller-Lopez, Ana B. Hitos, Celia Sequera, Flavio Maina, Angela M. Valverde

Summary: There is compelling evidence that the MET receptor tyrosine kinase plays a significant role in liver development, regeneration, insulin resistance, and obesity.

CELLS (2022)

Article Oncology

Lack of EGFR catalytic activity in hepatocytes improves liver regeneration following DDC-induced cholestatic injury by promoting a pro-restorative inflammatory response

Nerea Lazcanoiturburu, Juan Garcia-Saez, Carlos Gonzalez-Corralejo, Cesareo Roncero, Julian Sanz, Carlos Martin-Rodriguez, M. Pilar Valdecantos, Adoracion Martinez-Palacian, Laura Almale, Paloma Bragado, Silvia Calero-Perez, Almudena Fernandez, Maria Garcia-Bravo, Carmen Guerra, Lluis Montoliu, Jose Carlos Segovia, Angela M. Valverde, Isabel Fabregat, Blanca Herrera, Aranzazu Sanchez

Summary: Inactivating EGFR signaling in the liver can reduce liver damage and promote efficient regeneration following cholestatic injury. This effect involves enhanced activation of mitogenic/survival signals and changes in cell turnover, which are associated with differences in the profile of intrahepatic immune cells.

JOURNAL OF PATHOLOGY (2022)

Article Oncology

Germline gain-of-function MMP11 variant results in an aggressive form of colorectal cancer

Lorena Martin-Morales, Sara Manzano, Maria Rodrigo-Faus, Adrian Vicente-Barrueco, Victor Lorca, Gonzalo Nunez-Moreno, Paloma Bragado, Almudena Porras, Trinidad Caldes, Pilar Garre, Alvaro Gutierrez-Uzquiza

Summary: A variant in the MMP11 gene has been identified to increase the tumorigenic properties of colorectal cancer cells, potentially leading to early onset of colorectal cancer. Further study of this gene in other colorectal cancer cases may improve patient treatment in the future.

INTERNATIONAL JOURNAL OF CANCER (2023)

Review Biochemistry & Molecular Biology

SLU7: A New Hub of Gene Expression Regulation-From Epigenetics to Protein Stability in Health and Disease

Maria Garate-Rascon, Miriam Recalde, Carla Rojo, Maite G. Fernandez-Barrena, Matias A. Avila, Maria Arechederra, Carmen Berasain

Summary: SLU7 is a splicing factor that affects the diversity of gene transcripts and serves as an integrative hub for gene expression regulation. It plays critical roles in liver differentiation, genome integrity, and cell cycle progression. Aberrant expression of SLU7 may be associated with human diseases including cancer.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Cell Biology

New functions of C3G in platelet biology: Contribution to ischemia-induced angiogenesis, tumor metastasis and TPO clearance

Luis Hernandez-Cano, Cristina Fernandez-Infante, Oscar Herranz, Pablo Berrocal, Francisco S. Lozano, Manuel A. Sanchez-Martin, Almudena Porras, Carmen Guerrero

Summary: C3G is a key factor in controlling platelet activation, aggregation, and the release of alpha-granule content, as well as promoting platelet-mediated angiogenesis and metastasis. It also plays a role in megakaryocyte maturation and platelet formation, and affects platelet production and internalization. These findings highlight the crucial role of C3G in regulating platelet functions and its involvement in pathological conditions.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)

Article Cell Biology

Crk proteins activate the Rap1 guanine nucleotide exchange factor C3G by segregated adaptor-dependent and -independent mechanisms

Antonio Rodriguez-Blazquez, Arturo Carabias, Alba Moran-Vaquero, Sergio de Cima, Juan R. Luque-Ortega, Carlos Alfonso, Peter Schuck, Jose Antonio Manso, Sandra Macedo-Ribeiro, Carmen Guerrero, Jose M. de Pereda

Summary: C3G activation is regulated by phosphorylation and interaction with Crk adaptor proteins, revealing a two-factor mechanism for tight control of its activity.

CELL COMMUNICATION AND SIGNALING (2023)

Article Cell Biology

MYC and MET cooperatively drive hepatocellular carcinoma with distinct molecular traits and vulnerabilities

Celia Sequera, Margherita Grattarola, Agnes Holczbauer, Rosanna Dono, Stefania Pizzimenti, Giuseppina Barrera, Kirk J. Wangensteen, Flavio Maina

Summary: Enhanced activation of MYC and MET has been found in hepatocellular carcinoma (HCC), and their co-occurrence is associated with poor prognosis. In vivo experiments showed that MYC and MET overexpression in hepatocytes is sufficient to induce liver tumorigenesis, and it also affects the expression of various genes and immune checkpoints. In vitro evidence suggests that some HCC cell lines, which are resistant to single inhibition, are vulnerable to combined MYC and MET targeting.

CELL DEATH & DISEASE (2022)

Article Biochemistry & Molecular Biology

C3G down-regulation enhances pro-migratory and stemness properties of oval cells by promoting an epithelial-mesenchymal-like process

Nerea Palao, Celia Sequera, Angel M. Cuesta, Cristina Baquero, Paloma Bragado, Alvaro Gutierrez-Uzquiza, Aranzazu Sanchez, Carmen Guerrero, Almudena Porras

Summary: The knock-down of C3G enhances the migratory and invasive ability of oval cells and increases the expression of stemness markers. It also enhances the clonogenic capacity of oval cells. The knock-down of C3G impairs HGF/MET signaling and increases TGF-beta signaling in oval cells.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2022)

No Data Available